Diagnosis and Treatment of Alternating Hemiplegia of Childhood

  • Melanie Masoud
  • Lyndsey Prange
  • Jeffrey Wuchich
  • Arsen Hunanyan
  • Mohamad A. Mikati
Pediatric Neurology (R-M Boustany, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Pediatric Neurology

Opinion statement

The diagnosis and treatment of patients with Alternating Hemiplegia of Childhood (AHC) and related disorders should be provided by a multidisciplinary team experienced with the spectrum of presentations of this disease, with its related disorders, with its complex and fluctuating manifestations, and with cutting edge advances occurring in the field. Involvement in research to advance the understanding of this disease and partnership with international collaborators and family organizations are also important. An example of such an approach is that of The Duke AHC and Related Disorders Multi-Disciplinary Clinic and Program, which, in partnership with the Cure AHC Foundation, has developed and applied this approach to patients seen since early 2013. The program provides comprehensive care and education directly to AHC patients and their families and collaborates with referring physicians on the care of patients with AHC whether evaluated at Duke clinics or not. It also is involved in clinical and basic research and in collaborations with other International AHC Research Consortium (IAHCRC) partners. The clinic is staffed with physicians and experts from Neurology, Cardiology, Child Behavioral Health, Medical Genetics, Neurodevelopment, Neuropsychology, Nursing, Physical and Occupational Therapies, Psychiatry, Sleep Medicine, and Speech/Language Pathology. Patients are seen either for full comprehensive evaluations that last several days or for targeted evaluations with one or few appointments.

Keywords

Alternating hemiplegia of childhood Hemiplegia ATP1A3 Treatment Diagnosis Flunarizine 

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Neville BG, Ninan M. The treatment and management of alternating hemiplegia of childhood. Dev Med Child Neurol. 2007;49(10):777–80.CrossRefPubMedGoogle Scholar
  2. 2.
    Verret S, Steele JC. Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy. Pediatrics. 1971;47(4):675–80.PubMedGoogle Scholar
  3. 3.
    Lagman-Bartolome AM, Lay C. Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome. Curr Neurol Neurosci Rep. 2015;15(6):34.CrossRefPubMedGoogle Scholar
  4. 4.
    •• Heinzen EL et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet. 2012;44(9):1030–4. This study established that AHC in the majority of patients is caused by mutations of the ATP1A3 gene and that such mutations cause loss of function of enzyme activity without reducing the expression of that protein.Google Scholar
  5. 5.
    •• Rosewich H et al. heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol. 2012;11(9):764-73. This article, concurrently with above article, established that ATP1A3 mutations cause AHC.Google Scholar
  6. 6.
    Bottger P et al. Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain. J Comp Neurol. 2011;519(2):376–404.CrossRefPubMedGoogle Scholar
  7. 7.
    •• Panagiotakaki E et al. Clinical profile of patients with ATP1A3 mutations in alternating hemiplegia of childhood-a study of 155 patients. Orphanet J Rare Dis. 2015;10:123. This article is the most recent study that provides a detailed study of the genotype-phenotype correlations in AHC.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    •• Mikati MA et al. A syndrome of autosomal dominant alternating hemiplegia: clinical presentation mimicking intractable epilepsy; chromosomal studies; and physiologic investigations. Neurology. 1992;42(12):2251–7. This article reported the first family with AHC establishing genetic etiology of the disorder for the first time.Google Scholar
  9. 9.
    Mikati M, O’Tuama L, Dangond F. Autosomal dominant alternating hemiplegia of childhood. Alternating hemiplegia of childhood. 1995. p. 125–134.Google Scholar
  10. 10.
    Swoboda KJ et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann Neurol. 2004;55(6):884–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Bassi MT et al. A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J Med Genet. 2004;41(8):621–8.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Kramer U et al. Alternating hemiplegia of childhood in half-sisters. J Child Neurol. 2000;15(2):128–30.CrossRefPubMedGoogle Scholar
  13. 13.
    Li M et al. A functional correlate of severity in alternating hemiplegia of childhood. Neurobiol Dis. 2015;77:88–93.CrossRefPubMedGoogle Scholar
  14. 14.
    Viollet L et al. Alternating hemiplegia of childhood: retrospective genetic study and genotype-phenotype correlations in 187 subjects from the US AHCF registry. PLoS ONE. 2015;10(5):e0127045.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Yang X et al. ATP1A3 mutations and genotype-phenotype correlation of alternating hemiplegia of childhood in Chinese patients. PLoS ONE. 2014;9(5):e97274.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Sasaki M et al. Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology. 2014;82(6):482–90.CrossRefPubMedGoogle Scholar
  17. 17.
    Heinzen EL et al. Distinct neurological disorders with ATP1A3 mutations. Lancet Neurol. 2014;13(5):503–14.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Sweney MT, Newcomb TM, Swoboda KJ. The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, alternating hemiplegia of childhood, rapid-onset dystonia-parkinsonism, CAPOS and beyond. Pediatr Neurol. 2015;52(1):56–64.CrossRefPubMedGoogle Scholar
  19. 19.
    Heimer G et al. CAOS-episodic cerebellar ataxia, areflexia, optic atrophy, and sensorineural hearing loss: a third allelic disorder of the ATP1A3 gene. J Child Neurol. 2015;30(13):1749–56.CrossRefPubMedGoogle Scholar
  20. 20.
    Dard R et al. Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation. Dev Med Child Neurol. 2015;57(12):1183–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Paciorkowski AR et al. Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly. Epilepsia. 2015;56(3):422–30.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Termsarasab P, Yang AC, Frucht SJ. Intermediate phenotypes of ATP1A3 mutations: phenotype-genotype correlations. Tremor Other Hyperkinet Mov (NY). 2015;5:336.Google Scholar
  23. 23.
    Demos MK et al. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rare Dis. 2014;9:15.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Bourgeois M, Aicardi J, Goutières F. Alternating hemiplegia of childhood. J Pediatr. 1993;122(5):673–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Mikati MA et al. Alternating hemiplegia of childhood: clinical manifestations and long-term outcome. Pediatr Neurol. 2000;23(2):134–41.CrossRefPubMedGoogle Scholar
  26. 26.
    Andermann E et al. Benign familial nocturnal alternating hemiplegia of childhood. Neurology. 1994;44(10):1812–4.CrossRefPubMedGoogle Scholar
  27. 27.
    Saito Y et al. A case of alternating hemiplegia of childhood with cerebellar atrophy. Pediatr Neurol. 1998;19(1):65–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Kansagra S, Mikati MA, Vigevano F. Alternating hemiplegia of childhood. Handb Clin Neurol. 2013;112:821–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Cornelio-Nieto JO et al. Acute hemiplegia in childhood and alternating hemiconvulsions secondary to Moya-Moya disease. Report of a case associated with Down’s syndrome. Bol Med Hosp Infant Mex. 1990;47(1):39–42.PubMedGoogle Scholar
  30. 30.
    Carlson CB, Harvey FH, Loop J. Progressive alternating hemiplegia in early childhood and basal arterial stenosis and telangiectasia (moyamoya syndrome). Neurology. 1973;23(7):734–44.CrossRefPubMedGoogle Scholar
  31. 31.
    Montagna P et al. MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology. 1988;38(5):751–4.CrossRefPubMedGoogle Scholar
  32. 32.
    Mikati M, Fischman A. PET scan findings in alternating hemiplegia of childhood. Alternating hemiplegia of childhood. 1995. p. 109–114.Google Scholar
  33. 33.
    Dangond F et al. Focal brain dysfunction in a 41-year old man with familial alternating hemiplegia. Eur Arch Psychiatry Clin Neurosci. 1997;247(1):35–41.CrossRefPubMedGoogle Scholar
  34. 34.
    Panagiotakaki E et al. Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults. Brain. 2010;133(Pt 12):3598–610.Google Scholar
  35. 35.
    •• Jaffer F et al. Faulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotype. Brain. 2015;138(Pt 10):2859–74. This study established that AHC patients have also cardiac abnormalities that potentially could prove to be contributing to the increased risks of motality in these patients.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    •• Hunanyan AS et al. Knock-in mouse model of alternating hemiplegia of childhood: behavioral and electrophysiologic characterization. Epilepsia. 2015;56(1):82–93. This study described the, to date, the mouse model that most closely reproduces the human condition and characterized electrophysiological properties in it.CrossRefPubMedGoogle Scholar
  37. 37.
    Tenney JR, Schapiro MB. Child neurology: alternating hemiplegia of childhood. Neurology. 2010;74(14):e57–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Sasaki M, Sakuragawa N, Osawa M. Long-term effect of flunarizine on patients with alternating hemiplegia of childhood in Japan. Brain Dev. 2001;23(5):303–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Pledger GW et al. Flunarizine for treatment of partial seizures: results of a concentration-controlled trial. Neurology. 1994;44(10):1830–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Chi LY et al. Alternating hemiplegia of childhood in chinese following long-term treatment with flunarizine or topiramate. Int J Neurosci. 2012;122(9):506–10.CrossRefPubMedGoogle Scholar
  41. 41.
    Jiang W et al. Topiramate: a new agent for patients with alternating hemiplegia of childhood. Neuropediatrics. 2006;37(4):229–33.CrossRefPubMedGoogle Scholar
  42. 42.
    Roubergue A et al. Excellent response to a ketogenic diet in a patient with alternating hemiplegia of childhood. JIMD Rep. 2015;15:7–12.PubMedGoogle Scholar
  43. 43.
    Vila-Pueyo M et al. Clinical and genetic analysis in alternating hemiplegia of childhood: ten new patients from Southern Europe. J Neurol Sci. 2014;344(1–2):37–42.CrossRefPubMedGoogle Scholar
  44. 44.
    Haffejee S, Santosh PJ. Treatment of alternating hemiplegia of childhood with aripiprazole. Dev Med Child Neurol. 2009;51(1):74–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Badoe EV. Alternating hemiplegia in a child misdiagnosed as intractable epilepsy successfully treated with aripiprazole: a case report. West Afr J Med. 2011;30(2):140–4.PubMedGoogle Scholar
  46. 46.
    Wong VC, Kwong AK. ATP1A3 mutation in a Chinese girl with alternating hemiplegia of childhood--Potential target of treatment? Brain Dev. 2015;37(9):907–10.CrossRefPubMedGoogle Scholar
  47. 47.
    Sone K et al. Successful trial of amantadine hydrochloride for two patients with alternating hemiplegia of childhood. Neuropediatrics. 2000;31(6):307–9.CrossRefPubMedGoogle Scholar
  48. 48.
    Ju J et al. Treatment with oral ATP decreases alternating hemiplegia of childhood with de novo ATP1A3 mutation. Orphanet J Rare Dis. 2016;11(1):55.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Kirshenbaum GS et al. Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+, K+−ATPase alpha3 sodium pump. Proc Natl Acad Sci U S A. 2011;108(44):18144–9.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Ohnishi T et al. Na, K-ATPase alpha3 is a death target of Alzheimer patient amyloid-beta assembly. Proc Natl Acad Sci U S A. 2015;112(32):E4465–74.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Tanner GR et al. Single K ATP channel opening in response to action potential firing in mouse dentate granule neurons. J Neurosci. 2011;31(23):8689–96.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Holm TH et al. Cognitive deficits caused by a disease-mutation in the alpha3 Na(+)/K(+)-ATPase isoform. Sci Rep. 2016;6:31972.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Masoud M et al. Characterization and Analysis of Inter-relationships of Motor Function Domains in Patients with Alternating Hemiplegia of Childhood. Developmental Medicine and Child Neurology, in press.Google Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Melanie Masoud
    • 1
  • Lyndsey Prange
    • 1
  • Jeffrey Wuchich
    • 2
  • Arsen Hunanyan
    • 1
  • Mohamad A. Mikati
    • 1
  1. 1.Duke University Children Health CenterDurhamUSA
  2. 2.Cure AHC, Inc.RolesvilleUSA

Personalised recommendations